Silymarin: What is in the name …? An appeal for a change of editorial policy

This publication has 13 references indexed in Scilit:

• Significant inhibition by the flavonoid antioxidant silymarin against 12-O-tetradecanoylphorbol 13-acetate-caused modulation of antioxidant and inflammatory enzymes, and cyclooxygenase 2 and interleukin-1? expression in SENCAR mouse epidermis: Implications in the prevention of stage I tumor promotion
  Molecular Carcinogenesis, 1999
• Herbal products for liver diseases: A therapeutic challenge for the new millennium
  Hepatology, 1999
• Activities of silymarin and its flavonolignans upon low density lipoprotein oxidizability in vitro
  Phytotherapy Research, 1999
• Milk Thistle ( Silybum marianum ) for the Therapy of Liver Disease
  American Journal of Gastroenterology, 1998
• Effect of antifibrotic agent silymarin on liver cell regeneration in a rat model of secondary biliary fibrosis: a morphometric analysis
  Phytotherapy Research, 1998
• Silymarin retards collagen accumulation in early and advanced biliary fibrosis secondary to complete bile duct obliteration in rats
  Hepatology, 1997
• Glycosylation of silybin
  Journal of the Chemical Society, Perkin Transactions 1, 1997
• Silibinin protects against cisplatin-induced nephrotoxicity without compromising cisplatin or ifosfamide anti-tumour activity
  British Journal of Cancer, 1996
• Two high-performance liquid chromatographic assays for the determination of free and total silibinin diastereomers in plasma using column switching with electrochemical detection and reversed-phase chromatography with ultraviolet detection
  Journal of Chromatography B: Biomedical Sciences and Applications, 1995
• Evaluation of the silymarin content in Silybum marianum (L.) Gaertn. Cultivated under different agricultural conditions
  Phytotherapy Research, 1993